On March 16, a number of Listed Companies in Shanghai and Shenzhen issued announcements. The following is a summary of important announcements
major issues
Embedway Technologies (Shanghai) Corporation(603496) : the controlling shareholder intends to transfer 6.14% shares to Mingyuan Xinchuang No. 1
Embedway Technologies (Shanghai) Corporation(603496) ( Embedway Technologies (Shanghai) Corporation(603496) ) it was announced on March 16 that the controlling shareholders Shen Zhenyu, Hu Deyong and Wang Xiang signed the share transfer agreement with Mingyuan Xinchuang No. 1 and transferred their 6.14% of the company’s shares to Mingyuan Xinchuang No. 1 at the price of 10.38 yuan / share. This equity change does not touch the tender offer. This equity change will not lead to changes in the controlling shareholders and actual controllers of the company.
Liaoning Chengda Biotechnology Co.Ltd(688739) : the application for clinical trial of acyw135 meningococcal polysaccharide conjugate vaccine was accepted
Liaoning Chengda Biotechnology Co.Ltd(688739) ( Liaoning Chengda Biotechnology Co.Ltd(688739) ) announced on March 16 that the company recently received the acceptance notice approved and issued by the State Drug Administration, and the application for clinical trial of acyw135 meningococcal polysaccharide conjugate vaccine was accepted. Within 60 days from the date of acceptance, if no negative or questioning opinions are received from the drug trial center, the company can carry out clinical trials according to the submitted scheme.
Shandong Buchang Pharmaceuticals Co.Ltd(603858) : Xuanfei Baidu granule is listed in covid-19 pneumonia diagnosis and treatment plan (trial version 9)
Shandong Buchang Pharmaceuticals Co.Ltd(603858) ( Shandong Buchang Pharmaceuticals Co.Ltd(603858) ) March 16th announcement, recently, the office of the national health and Health Committee and the office of the State Administration of traditional Chinese medicine jointly issued the New Coronavirus pneumonia diagnosis and treatment plan (trial version ninth).
Humanwell Healthcare (Group) Co.Ltd(600079) : remazolam besylate for injection has increased the indication and obtained the drug registration certificate
Humanwell Healthcare (Group) Co.Ltd(600079) ( Humanwell Healthcare (Group) Co.Ltd(600079) ) announced on March 16 that Yichang humanwell, a holding subsidiary, recently received the drug registration certificate approved and issued by the State Drug Administration on the increased indications of remazolam besylate for injection.
torch core technology: the office of the company affected by the epidemic is sealed
Torch core technology (688049) March 16th announcement, according to the Department concerned, Zhuhai high tech Zone New Coronavirus pneumonia epidemic prevention command headquarters to control the company, isolation according to the provisions of the epidemic prevention needs of the relevant personnel, the implementation of “regional closed, stay indoors, door-to-door” management measures. This time, only the office space located in Building 1, Juli science and Technology Park, No. 1, Keji Fourth Road, Zhuhai high tech Zone is sealed off. Therefore, it will not have a significant impact on the company’s production and operation and product delivery. Considering the recent continuous cycle of covid-19 epidemic in various places, the closure and control of the company is a short-term measure for epidemic prevention, which will not have an adverse impact on the medium and long-term development of the company.
Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) : Xuebijing injection is included in the New Coronavirus pneumonia diagnosis and treatment plan (trial version ninth)
Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) ( Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) ) March 16th announcement, in March 15th, the national health and Health Commission and the State Administration of traditional Chinese medicine jointly issued the New Coronavirus pneumonia diagnosis and treatment plan (trial version ninth). Xuebijing injection, the company’s product, is listed as the recommended medication for severe and dangerous cases in the clinical treatment period (confirmed cases).
Zhejiang Orient Gene Biotech Co.Ltd(688298) : New Coronavirus antigen test kit has obtained China medical device registration certificate
Zhejiang Orient Gene Biotech Co.Ltd(688298) ( Zhejiang Orient Gene Biotech Co.Ltd(688298) ) March 16th announcement, the company independently developed New Coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) in March 15, 2022 to obtain the National Drug Administration (NMPA) issued the “People’s Republic of China medical device registration card (in vitro diagnostic reagents)”.
Hangzhou Everfine Photo-E-Info Co.Ltd(300306) : the company is not directly involved in electronic ID card business
Hangzhou Everfine Photo-E-Info Co.Ltd(300306) ( Hangzhou Everfine Photo-E-Info Co.Ltd(300306) ) announced on March 16 that the company was concerned about media reports that the company was involved in electronic ID card business. The company’s biometric business is the main business of Zhejiang Weier Technology Co., Ltd., the holding subsidiary of the company. At present, it mainly focuses on the biometric technology, product and service market, focusing on developing business in traffic driving training, finance and banking, public safety, military industry and other industries. Up to now, the company has not been directly involved in electronic ID card business.
China Meheco Group Co.Ltd(600056) : covid-19 virus treatment drugs may affect the sales price if they are included in the national medical insurance
China Meheco Group Co.Ltd(600056) ( China Meheco Group Co.Ltd(600056) ) March 16th announcement, March 15th, the National Health Council released the New Coronavirus pneumonia diagnosis and treatment plan (trial version ninth), Pfizer Inc COVID-19 virus treatment drug PAXLOVID included in the ninth edition of the diagnosis and treatment plan, but has not yet entered the national health insurance. If it is included in the national medical insurance, it may have an impact on the sales price. The company signed an agreement with Pfizer Inc in March 9th, and the company will be responsible for the commercial operation of Pfizer Inc COVID-19 virus PAXLOVID in Chinese mainland market during the agreement period (2022).
Beijing Compass Technology Development Co.Ltd(300803) : it is proposed to acquire 100% equity of restructured wechat securities by RMB 1.5 billion
Beijing Compass Technology Development Co.Ltd(300803) ( Beijing Compass Technology Development Co.Ltd(300803) ) announced on March 16 that it plans to participate in the bankruptcy and reorganization of wechat securities, invest 1.5 billion yuan to obtain 100% equity of the restructured wechat securities and become its controlling shareholder. As the target company has been in abnormal operation in recent years, the historical financial data can not reflect the real value of the target company.
Tahoe Group Co.Ltd(000732) : Huang Qisen, chairman and general manager of the company, is assisting relevant authorities in the investigation
Tahoe Group Co.Ltd(000732) ( Tahoe Group Co.Ltd(000732) ) it was announced on March 16 that Huang Qisen, chairman and general manager of the company, was assisting relevant authorities in the investigation. The board of directors of the company has launched the emergency plan. At present, Ge Yong, CO president of the company, and Wang Jinggang, CO president of the company, normally preside over the production and operation of the company.
Guangzhou Lingnan Group Holdings Company Limited(000524) : it is expected to usher in more positive factors in the future to promote the recovery and development of the tourism market
Guangzhou Lingnan Group Holdings Company Limited(000524) ( Guangzhou Lingnan Group Holdings Company Limited(000524) ) announced on March 16 that although the Chinese tourism market is affected by the epidemic situation in various places and the outbound tourism market has not been restarted, with the popularization of covid-19 vaccine and the continuous introduction of specific drugs, it is expected to usher in more positive factors to promote the recovery and development of the tourism market in the future.
Facing the market changes after the normalization of epidemic prevention and control, the company will actively grasp the new demand, integrate into the new development pattern, constantly deepen the transformation and upgrading, innovate and supply in one main and multiple ways, and continue to promote the layout of the company’s Pan tourism industry ecosystem
performance express
Shenghe Resources Holding Co.Ltd(600392) : the net profit in the first two months increased by about 259% year-on-year
Shenghe Resources Holding Co.Ltd(600392) ( Shenghe Resources Holding Co.Ltd(600392) ) announced on March 16 that according to the preliminary accounting of the company, from January to February 2022, the company realized an operating revenue of about 2.671 billion yuan, a year-on-year increase of about 126.74%; The net profit attributable to the parent company was about 456 million yuan, with a year-on-year increase of about 259.06%. The company’s revenue and profit increased significantly, mainly due to the continuous improvement in the demand for major rare earth products, the company’s sufficient orders, and the large increase in product prices in the same period. The company’s subordinate factories arrange orders for production and solidly carry out production and operation.
Shanghai Microport Endovascular Medtech (Group) Co.Ltd(688016) : the revenue in the first two months increased by about 35% year-on-year
The company’s business income increased by about RMB 6887 billion in the same period of last year, up from about 3.6 billion in the same period of last year.
Shanghai Laimu Electronics Co.Ltd(603633) : the net profit in the first two months increased by about 30% – 35% year-on-year
Shanghai Laimu Electronics Co.Ltd(603633) ( Shanghai Laimu Electronics Co.Ltd(603633) ) announced on March 16 that the operating revenue from January to February was about 140 million yuan to 142 million yuan, an increase of about 40% to 42% over the same period last year, and the net profit was about 101267 million yuan to 105262 million yuan, an increase of about 30% to 35% over the same period last year. In the coming years, with the rapid development of intelligent, networking, automatic driving and China’s hybrid power system, the company will continuously improve the product layout of the overall solution of the electronic and electrical architecture, such as millimeter wave radar module, laser radar module, domain controller system, automatic driving system, intelligent cockpit system, electronic control system, and so on, and new products have been put into operation.
Sansteel Minguang Co.Ltd.Fujian(002110) performance express: net profit of 3.979 billion yuan in 2021, with a year-on-year increase of 55.69%
Sansteel Minguang Co.Ltd.Fujian(002110) ( Sansteel Minguang Co.Ltd.Fujian(002110) ) disclosed the annual performance express of 2021 on March 16. In 2021, the company realized an operating revenue of 62.753 billion yuan, an increase of 29.02% year-on-year; The net profit attributable to the shareholders of the listed company is expected to be 3.979 billion yuan, a year-on-year increase of 55.69%. In 2021, the steel industry operated well, and the steel price rose year-on-year. The company seized the market opportunity, deepened fine management, optimized product structure, continued to improve production and operation, and realized a significant increase in net profit attributable to shareholders of listed companies over the same period of last year.
Shan Xi Hua Yang Group New Energy Co.Ltd(600348) performance express: net profit in 2021 increased by 134% year-on-year
Shan Xi Hua Yang Group New Energy Co.Ltd(600348) ( Shan Xi Hua Yang Group New Energy Co.Ltd(600348) ) released the performance express on March 16, realizing an operating revenue of 38 billion yuan in 2021, with a year-on-year increase of 21.89%; The net profit attributable to the parent company was 3.528 billion yuan, a year-on-year increase of 134.44%. During the reporting period, the coal market demand was strong, and the prices of the company’s main coal products increased significantly year-on-year.
Yongxing Special Materials Technology Co.Ltd(002756) : the net profit from January to February increased by about 650% year-on-year
Yongxing Special Materials Technology Co.Ltd(002756) ( Yongxing Special Materials Technology Co.Ltd(002756) ) announced on March 16 that from January to February, the company achieved an operating revenue of about 1.58 billion yuan, a year-on-year increase of about 96%, and a net profit attributable to shareholders of listed companies of about 490 million yuan, a year-on-year increase of about 650%. The company’s performance growth is mainly due to the continuous rapid development of lithium battery new energy industry, which drives the rising price of lithium carbonate. From January to February, the company’s lithium new energy business achieved an operating revenue of about 620 million yuan, a year-on-year increase of about 670%, and the net profit attributable to shareholders of listed companies was about 420 million yuan, a year-on-year increase of about 3700%.
China National Medicines Corporation Ltd(600511) : the net profit in 2021 increased by 26.86% year-on-year, and it is proposed to pay 7 yuan out of 10
China National Medicines Corporation Ltd(600511) ( China National Medicines Corporation Ltd(600511) ) disclosed the annual report of 2021 on March 16. During the reporting period, the company achieved an operating revenue of 46.469 billion yuan, an increase of 15.08% year-on-year; The net profit was 1.754 billion yuan, a year-on-year increase of 26.86%; The basic earnings per share is 2.32 yuan. The company plans to pay a cash dividend of 7.00 yuan (including tax) for every 10 shares.
Changchun High And New Technology Industries (Group) Inc(000661) : the net profit in 2021 increased by 23.33% year-on-year, and it is proposed to pay 8 yuan out of 10
Changchun High And New Technology Industries (Group) Inc(000661) ( Changchun High And New Technology Industries (Group) Inc(000661) ) disclosed the annual report of 2021 on March 16. During the reporting period, the company realized an operating revenue of 10.747 billion yuan, an increase of 25.30% year-on-year; The net profit was 3.757 billion yuan, a year-on-year increase of 23.33%; The basic earnings per share is 9.28 yuan. The company plans to distribute a cash dividend of 8.00 yuan (including tax) to all shareholders for every 10 shares
major investment
Zhuzhou Kibing Group Co.Ltd(601636) : it is proposed to invest 3.12 billion yuan to build two photovoltaic glass production lines
Zhuzhou Kibing Group Co.Ltd(601636) ( Zhuzhou Kibing Group Co.Ltd(601636) ) announced on March 16 that it plans to invest 3.12 billion yuan to build two 1200td photovoltaic glass production lines; It is planned to invest 850 million yuan to build a quartz sand production base in Malaysia; It is proposed to invest 490 million yuan in the construction of roof distributed photovoltaic power station project.
Sichuan Crun Co.Ltd(002272) : Sun company plans to invest in Lufeng offshore wind power supporting intelligent production project
Sichuan Crun Co.Ltd(002272) ( Sichuan Crun Co.Ltd(002272) ) on March 16, it was announced that chuanrun new energy technology (Guangdong) Co., Ltd., a wholly-owned subsidiary, plans to invest in Lufeng offshore wind power supporting intelligent production project, and the investment amount is estimated to be no more than 100 million yuan.
Shanxi Xinghuacun Fen Wine Factory Co.Ltd(600809) : it is proposed to invest 9.102 billion yuan in the expansion project of original wine production and energy storage
Shanxi Xinghuacun Fen Wine Factory Co.Ltd(600809) ( Shanxi Xinghuacun Fen Wine Factory Co.Ltd(600809) ) announced on March 16 that the company plans to invest 9.102 billion yuan in the construction and implementation of Fenjiu 2030 technical transformation original wine production and storage expansion project (phase I). The project covers an area of 1932 Mu and the construction period is planned to be three years. After the completion of the project, the company is expected to increase the annual output of original wine by 51000 tons and the energy storage of original wine by 134400 tons.
Guangdong No.2 Hydropower Engineering Company Ltd(002060) : the subsidiary plans to invest 6.3 billion yuan to build a new energy power generation project with a total installed capacity of 1.05 million KW
Guangdong No.2 Hydropower Engineering Company Ltd(002060) ( Guangdong No.2 Hydropower Engineering Company Ltd(002060) ) announced on March 16 that recently, Xinjiang Guangdong No.2 Hydropower Engineering Company Ltd(002060) , a wholly-owned subsidiary of the company, signed a framework agreement with the people’s Government of Weining County, Bijie City, Guizhou Province. The people’s Government of Weining County agreed that Xinjiang Guangdong No.2 Hydropower Engineering Company Ltd(002060) would invest in the construction of a new energy power generation project with a total installed capacity of 1.05 million kW in Weining County, with a total investment of about 6.3 billion yuan.
Among them, the proposed construction scale of distributed photovoltaic project is about 50000 kW, with a total investment of about 300 million yuan; The centralized photovoltaic power generation project is 800000 kW (photovoltaic + agriculture, aquaculture, hydrogen production, energy storage, etc.), and the wind power generation project is 200000 kW, with a total investment of about 6 billion yuan Contract signing
Zhejiang Century Huatong Group Co.Ltd(002602) : holding subsidiary and Zte Corporation(000063) signed strategic cooperation framework agreement
Zhejiang Century Huatong Group Co.Ltd(002602) ( Zhejiang Century Huatong Group Co.Ltd(002602) ) announced on March 16 that century Longteng, the holding subsidiary of the company, signed the strategic cooperation framework agreement with Zte Corporation(000063) on March 15. The two sides intend to carry out all-round cooperation in business fields such as data center, industrial park development, government cloud business development and 5g edge computing center. The agreement is valid for three years.
Nanjing Vazyme Biotech Co.Ltd(688105) : sign 215 million yuan New Coronavirus antigen test kit
Nanjing Vazyme Biotech Co.Ltd(688105) ( Nanjing Vazyme Biotech Co.Ltd(688105) ) on March 16, it was announced that Nanjing Vazyme Biotech Co.Ltd(688105) medical, a wholly-owned subsidiary of the company, recently signed a distribution contract with Shangyao medical. According to the contract, Nanjing Vazyme Biotech Co.Ltd(688105) medical authorized Shangyao medical is an authorized dealer of Nanjing Vazyme Biotech Co.Ltd(688105) medical in Shanghai, its 100% shareholder Shangyao Holding Co., Ltd. and its subsidiaries in the procurement project of medical materials for public health; The drug treatment plan to Nanjing Vazyme Biotech Co.Ltd(688105) medical procurement total 215 million yuan (including tax) New Coronavirus antigen detection kit. The above purchase amount exceeds 50% of the audited operating cost of the company in the latest fiscal year.
Hainan Jinpan Smart Technology Co.Ltd(688676) : 851 million yuan of new orders signed from January to February
Hainan Jinpan Smart Technology Co.Ltd(688676) ( Hainan Jinpan Smart Technology Co.Ltd(688676) ) announced on March 16 that due to the rapid development of the company’s industry and the steady growth of the company’s business, 851 million yuan of new orders were signed from January to February 2022. By the end of February 2022, the company’s orders on hand were 2.147 billion yuan, an increase of 58.15% over the same period of the previous year.
Lucky Harvest Co.Ltd(002965) : received the letter of intent for project designation, and the estimated transaction amount is 3-3.5 billion yuan
Lucky Harvest Co.Ltd(002965) ( Lucky Harvest Co.Ltd(002965) ) on March 16, it was announced that the company and its wholly-owned subsidiary Changshu Xiangxin received 14 letters of intent for fixed-point projects from customers related to power batteries from January to March, confirming that the company and Changshu Xiangxin are suppliers of many new energy vehicle power battery box products, with an estimated project life cycle of 2-8 years and an estimated project transaction amount of 3-3.5 billion yuan, The end customers of the project include Chinese independent automobile brands and joint venture brands
bid winning project
Tengda Construction Group Co.Ltd(600512) : won the bid for the project of RMB 310 million
Tengda Construction Group Co.Ltd(600512) ( Tengda Construction Group Co.Ltd(600512) ) announced on March 16 that the company was the bid winner of Ningbo “Yunfei road phase II (shaodu road Hongtang Middle Road) project (shaodu road Guangyuan Avenue) and Yaojiang New Area Comprehensive Pipe Gallery phase I (Yunfei Road) Civil Engineering (construction) bid section I”, with a bid price of 310 million yuan and a construction period of 730 calendar days.
Eastone Century Technology Co.Ltd(300310) : won the bid of 279 million yuan project
Eastone Century Technology Co.Ltd(300310) ( Eastone Century Technology Co.Ltd(300310) ) announced on March 16 that the company won the bid for the centralized procurement (equipment installation) project of communication engineering construction services of China Mobile from 2022 to 2023. The bid winning amount before discount is expected to be 279 million yuan (including tax), and the estimated execution period of the project is from January 1, 2022 to December 31, 2023
Unionman Technology Co.Ltd(688609) : it is proposed to repurchase shares of RMB 150 million to RMB 300 million
Unionman Technology Co.Ltd(688609) ( Unionman Technology Co.Ltd(688609) ) announced on March 16 that it planned to repurchase shares with 150 million yuan to 300 million yuan, and the repurchase price should not exceed 15 yuan / share.
Huizhou China Eagle Electronic Technology Co.Ltd(002579) : it is proposed to repurchase shares with RMB 50 million to RMB 90 million
The total amount of shares repurchased by the public shall not be less than RMB 900000, and the part of the company’s registered capital shall not be used for repurchase of shares by the public (no less than RMB 50000000); The price of repurchased shares shall not exceed 12 yuan / share.
Giant Network Group Co.Ltd(002558) : it is proposed to repurchase shares of RMB 300 million to RMB 600 million
Giant Network Group Co.Ltd(002558) ( Giant Network Group Co.Ltd(002558) ) announced on March 16 that the company plans to repurchase shares for the company’s employee stock ownership plan or equity incentive plan, the repurchase price is no more than 15 yuan / share, and the total repurchase amount is no more than 600 million yuan and no less than 300 million yuan.
Xiamen Intretech Inc(002925) : it is proposed to repurchase shares with RMB 100 million to RMB 200 million
Xiamen Intretech Inc(002925) ( Xiamen Intretech Inc(002925) ) announced on March 16 that the company plans to repurchase some public shares through centralized bidding with its own funds through the secondary market. The total amount of funds for this repurchase is not less than 100 million yuan and not more than 200 million yuan, and the repurchase price is not more than 24.90 yuan / share
increase and decrease
Changshu Tianyin Electromechanical Co.Ltd(300342) : shareholders and persons acting in concert intend to reduce their shares by no more than 2%
Changshu Tianyin Electromechanical Co.Ltd(300342) ( Changshu Tianyin Electromechanical Co.Ltd(300342) ) announced on March 16 that the shareholder Tianheng investment and its concerted actors Zhao Yunwen and Hengtai investment plan to reduce the shares of the company in the form of centralized bidding transaction, and the total reduction amount will not exceed 8500700 shares (accounting for 2% of the total share capital of the company), which will be carried out within 6 months after 15 trading days from the date of announcement of the reduction plan.
Chacha Food Company Limited(002557) : the controlling shareholder intends to increase the holding of shares of the company by 30 million yuan to 60 million yuan
Chacha Food Company Limited(002557) ( Chacha Food Company Limited(002557) ) it was announced on March 16 that Huatai Group, the controlling shareholder of the company, increased its holdings of 323300 shares of the company on March 15, accounting for 0.06% of the total share capital of the company, with an increase of RMB 149967 million. Within six months from March 15, the date of the initial increase, Huatai Group plans to continue to increase its shares in the company, with an increase of no less than 30 million yuan and no more than 60 million yuan (including 149967 million yuan).
Triumph Science & Technology Co.Ltd(600552) : the controlling shareholder increases the holding of 1.03% of the company’s shares, and plans to continue to increase the holding of with RMB 100 million-150 million
Triumph Science & Technology Co.Ltd(600552) ( Triumph Science & Technology Co.Ltd(600552) ) announced on March 16 that Kaisheng group, the controlling shareholder of the company, increased its holdings of 1.03% of the company’s shares through the bidding trading system of Shanghai Stock Exchange on March 16, 2022, and plans to continue to increase its holdings within 6 months after this increase, with a cumulative increase of no less than 100 million yuan and no more than 150 million yuan (including this increase).
refinancing
Hangzhou Star Shuaier Electric Appliance Co.Ltd(002860) : it is planned to issue convertible bonds to invest in the construction of 2gw high power generation Cecep Solar Energy Co.Ltd(000591) photovoltaic module project
Hangzhou Star Shuaier Electric Appliance Co.Ltd(002860) ( Hangzhou Star Shuaier Electric Appliance Co.Ltd(002860) ) announced on March 16 that the company plans to invest in the construction of 2gw high power generation Cecep Solar Energy Co.Ltd(000591) photovoltaic module project by publicly issuing convertible corporate bonds to unspecified objects, the company’s own funds and bank financing.
Jiajiayue Group Co.Ltd(603708) : it is proposed to raise no more than 608 million yuan
Jiajiayue Group Co.Ltd(603708) ( Jiajiayue Group Co.Ltd(603708) ) announced on March 16 that it is planned to raise no more than 608 million yuan for Jiajiayue Group Co.Ltd(603708) Shanghe smart Industrial Park Project (phase I), Yangting shopping plaza project and bank loan repayment.
Ling Yun Industrial Corporation Limited(600480) successfully raised 1.38 billion yuan in fixed amount: industrial investment fund, industrial development fund and other investment
Ling Yun Industrial Corporation Limited(600480) ( Ling Yun Industrial Corporation Limited(600480) ) the report on non-public offering of shares was disclosed on March 16. 153.5 million new shares were issued at an issue price of 8.99 yuan / share, and 1.38 billion yuan was raised in full, which was mainly used to expand automobile lightweight and motorized parts projects. The subscription objects include industrial investment fund Co., Ltd., Industrial Development Fund (limited partnership), zhongbing Investment Management Co., Ltd Ling Yun Industrial Corporation Limited(600480) said that the company comprehensively analyzed the market situation and the trend of the secondary market and selected the best issuance time. 52 institutions actively participated, with a subscription amount of 4.43 times. Industrial investment funds, central enterprise capital platforms and local state-owned assets platforms became investors, highlighting the recognition and confidence of the capital market in the company’s development and medium and long-term investment value
operating data
Shanghai International Airport Co.Ltd(600009) : passenger throughput in February increased by 89.42% year-on-year
Shanghai International Airport Co.Ltd(600009) ( Shanghai International Airport Co.Ltd(600009) ) announced on March 16 that 29000 aircraft took off and landed in February, with a year-on-year increase of 45.88%; The passenger throughput was 2.5573 million person times, with a year-on-year increase of 89.42%; The cargo and mail throughput was 265400 tons, a year-on-year decrease of 8.10%.
Shaanxi Construction Engineering Group Corporation Limited(600248) : the operating revenue in the first two months increased by about 4.53% year-on-year
Shaanxi Construction Engineering Group Corporation Limited(600248) ( Shaanxi Construction Engineering Group Corporation Limited(600248) ) announced on March 16 that according to the preliminary accounting of the company, from January to February 2022, the company achieved an operating revenue of 18.608 billion yuan, an increase of about 4.53% over the same period of last year. The company and its subsidiaries have signed 502 new contracts, with a newly signed contract amount of 43.674 billion yuan, an increase of about 8.33% over the same period of last year.
Ningbo Sanxing Medical Electric Co.Ltd(601567) : the operating revenue in the first two months increased by about 44% year-on-year
Ningbo Sanxing Medical Electric Co.Ltd(601567) ( Ningbo Sanxing Medical Electric Co.Ltd(601567) ) announced on March 16 that from January to February 2022, the company is expected to realize an operating revenue of about 1.15 billion yuan, a year-on-year increase of about 44%. From January to February 2022, the company’s intelligent power distribution sector is expected to achieve an operating revenue of about 900 million yuan, with a year-on-year increase of about 58%, mainly due to the sufficient overall orders on hand and more new orders.
Year on year growth of about 35
China National Nuclear Power Co.Ltd(601985) ( China National Nuclear Power Co.Ltd(601985) ) announced on March 16 that from January to February 2022, all units of the company operated well, and the company achieved a total operating revenue of about 10.9 billion yuan, an increase of about 27% year-on-year; The net profit attributable to shareholders of listed companies was about 1.6 billion yuan, an increase of about 50% year-on-year.
China Molybdenum Co.Ltd(603993) : the output of main products copper, cobalt and niobium increased by 20%, 52% and 42% respectively year-on-year in the first two months
China Molybdenum Co.Ltd(603993) ( China Molybdenum Co.Ltd(603993) ) announced on March 16 that from January to February 2022, the company seized the favorable opportunity of the market and went all out to stabilize and increase production. The output of the company’s main products copper, cobalt and niobium increased by 20%, 52% and 42% respectively year-on-year. The output of molybdenum and tungsten products decreased year-on-year due to the restriction of environmental protection management and control in major international competitions. At the same time, benefiting from the year-on-year increase in the sales prices of all products, the company’s main business indicators were better than expected and achieved a good start of the year. The company defines 2022 as the “construction year”, which is the key stage for the company to achieve “upgrading”. The company is accelerating the construction of two world-class mines in the Democratic Republic of Congo, maximizing the utilization value of resources and laying a solid foundation for the company to achieve new leaps. The construction of TFM mixed ore development project is progressing smoothly and is expected to be put into operation as scheduled. In the future, after the project is completed, the annual output of cathode copper will be increased by about 200000 tons, and the annual output of cobalt will be increased by about 17000 tons.
